… efficacy of oral ganciclovir in the prevention of CMV disease in persons with AIDS. … of CMV
disease in the placebo and ganciclovir groups. The time to the development of CMV disease …

… of valganciclovir with those of oral ganciclovir in preventing cytomegalovirus (CMV) disease
in high-… In this randomised, prospective, double-blind, double-dummy study, 364 CMV D+/R- …

… Cytomegalovirus (CMV) disease is a frequent cause of … used to prevent CMV infection and
disease have shown limited … efficacy of oral ganciclovir in the prevention of CMV disease …

… In this analysis, the risk of new cytomegalovirus disease was reduced by 39 percent among
patients taking oral ganciclovir as compared with placebo (P=0.02), confirming the primary …

… Ganciclovir prophylaxis for 4 weeks appears ineffective in heart allograft … /oral ganciclovir
therapy has shown greater efficacy in preventing CMV disease than sequential ganciclovir/…

… oral acyclovir group developed symptomatic CMV disease (… the oral ganciclovir group
developed symptomatic CMV disease (… with symptomatic CMV disease, 10 of 21 (48%) in the oral …

… Oral ganciclovir prevents CMV disease in patients with AIDS … A study comparing oral
ganciclovir (1000 mg every eight … those in the ganciclovir group had acquired CMV disease. There …

… prophylaxis, cytomegalovirus (CMV) disease is a … of oral ganciclovir with oral acyclovir after
induction with intravenous (IV) ganciclovir for long-term prophylaxis of CMV disease in CMV-…

… In this study, oral valacyclovir and intravenous ganciclovir had similar efficacies for prevention
of CMV disease in allogeneic BMT recipients. There were only 2 cases of CMV disease in …

… In a series of various SOT recipients with CMV disease, ganciclovir therapy resulted in
resolution of symptoms and signs in 89% of patients and no deaths were directly attributable to …